XML 20 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Statement of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
REVENUES:      
Sales Revenue, Services, Net $ 481,518 $ 470,259 $ 611,954
Sales Revenue, Goods, Net 178,291 124,482 185,566
Total Revenue 659,809 594,741 797,520
OPERATING EXPENSES:      
Cost of services, exclusive of depreciation shown below 334,074 331,688 387,739
Cost of product sales, exclusive of depreciation shown below 140,166 110,956 144,913
General and administrative expenses, exclusive of depreciation shown below 47,737 39,390 49,729
Depreciation 24,021 26,029 26,545
Amortization 919 843 912
Other Operating Income (Expense), Net (693) (344) 3,669
Severance and other charges 1,145 0 22,943
Income Before Interest Expense and Taxes 112,440 86,179 161,070
Interest expense 10,734 11,572 12,380
Income before income tax expense 101,706 74,607 148,690
Income Tax Expense (Benefit) 18,610 10,748 33,758
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 83,096 63,859 114,932
Net Income (Loss) Attributable to Noncontrolling Interest (29) (36) 85
Net income attributable to Core Laboratories N.V. $ 83,125 $ 63,895 $ 114,847
EARNINGS PER SHARE INFORMATION:      
Earnings Per Share, Basic $ 1.88 $ 1.47 $ 2.69
Earnings Per Share, Diluted 1.88 1.46 2.68
Cash dividends per share $ 2.20 $ 2.20 $ 2.20
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:      
Weighted Average Number of Shares Outstanding, Basic 44,153 43,479 42,747
Weighted Average Number of Shares Outstanding, Diluted 44,264 43,670 42,908